# Safety and Efficacy of Litramine in Overweight and Obese Subjects

> **NCT01233349** · PHASE3 · COMPLETED · sponsor: **InQpharm Group** · enrollment: 125 (actual)

## Conditions studied

- Overweight
- Obesity
- Weight Loss

## Interventions

- **DEVICE:** Litramine
- **DEVICE:** Placebo

## Key facts

- **NCT ID:** NCT01233349
- **Lead sponsor:** InQpharm Group
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2010-12
- **Final completion:** 2011-01
- **Target enrollment:** 125 (ACTUAL)
- **Last updated:** 2011-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01233349

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01233349, "Safety and Efficacy of Litramine in Overweight and Obese Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01233349. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*